MedTrace Logo

Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study

NCT02520817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2015-08-13

No results posted yet for this study

Summary

Minimal hepatic encephalopathy (MHE) can have a far-reaching impact on quality and ability to function in daily life and may progress to overt Hepatic Encephalopathy. Patients with MHE were missed in clinical follow up and are more exposure to work accident. The aim of the present study was to assess the effects of oral supplementation of antioxidant and zinc gluconate Versus Lactulose inTruck driver cirrhotic patients with MHE.

Conditions

  • Minimal Hepatic Encephalopathy

Interventions

DIETARY_SUPPLEMENT

175 mg zinc gluconate, 50000 IU vitamin A, 500 mg vitamin C and 100 mg vitamin E once daily plus lactulose; dose 30-60 ml/day for 3 months

DIETARY_SUPPLEMENT

Lactulose

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Tropical Medicine Tropical Medicine · Tropical Medicine

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02520817 on ClinicalTrials.gov